Details about the neuroanatomical projections from RSPv-a to ENTm
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|
| 91017 |
Retrosplenial area ventral part zone a | Entorhinal area medial part, dorsal zone |
strong | biotinylated dextran amine (BDA) | In the entorhinal area, labeled terminals were distributed, in patches, in layer III and layers V and VI at its rostralmost level (Figs. 1B,C, 2C) […]. Collator note: strong labeling in the mid-rostrocaudal ENTm, immediately caudal from the injection site. See Fig. 2C, Swanson Atlas Levels 41-43. | Shibata H, 1994 |
|---|
| 91018 |
Retrosplenial area ventral part zone a | Entorhinal area medial part, dorsal zone |
light/moderate | biotinylated dextran amine (BDA) | at more caudal levels, labeled terminals were distributed more diffusely in layers I, III, V and VI (Fig. 2D). Collator note: weak-moderate label in the more caudal ENTm. See Fig. 2D, Swanson Atlas Levels 44-45. | Shibata H, 1994 |
|---|
|
General description technique/protocol: […] injection into the caudal part of the RSG (Figs. 1A, 2A)[…]. Collator note: small BDA injection in the rostral RSPv-a. The injection site is mapped onto Swanson Atlas Levels 40-41. |
Further details associated to record number 91017:
| Position of injection: rostral |
| Topological position of injection: is contained |
| Extension of injection outside: none |
| The injection was performed in: right hemisphere |
| | Position of terminal field: mid-rostro-caudal |
| Topological position of terminal field: is contained |
| Extension of terminal field outside: none |
| The terminal field was found: ipsilateral |
| |
